|

6-23-04
Contacts:
Tracy Taylor Grondine (202)
406-3642
tracyg@fb.org
Mace Thornton
(202) 406-3641
macet@fb.org
SC
Farm Bureau President Testifies Before Congress on Importance
of Biotech
WASHINGTON, D.C. - In testimony today before a House
Agriculture subcommittee, the American Farm Bureau Federation
said domestic and international acceptance of biotechnology is
essential in maintaining competitive
U.S.
agricultural exports in the world market.
The increase in production of biotech crops in the United
States and abroad has increased the importance of developing
and maintaining markets, both domestically and
internationally. AFBF board member and South Carolina Farm
Bureau President David Winkles, who testified on behalf of
Farm Bureau, said market development for biotech agricultural
products depends on public policy that:
Maintains an unbiased, science-based regulatory system that
inspires consumer confidence and avoids unnecessary traceability
and labeling requirements for biotech commodities;
Defends against threats to market access for biotech crops and
expands access where current restrictions exist; and
Creates an environment conducive to the development of new
crop varieties enhanced through biotechnology.
"Requiring mandatory labeling and traceability of foods
containing commodities enhanced through biotechnology is
unnecessary with the regulatory system already in place," said
Winkles, discussing the different agencies that monitor
biotechnology and provide scientific evaluations of the
products.
Winkles said that if today's "unbiased, science-based
regulatory system" concludes that a product is safe for human
consumption, it is unnecessary to require labeling and other
restrictions.
"Consumers should not be forced to pay the cost of a mandatory
traceability and labeling system when the product in question
has been approved safe for human consumption." Winkles said.
Winkles said it was crucial to resolve biotech trade issues
with the European Union quickly to avoid further disruptions,
but the task could be daunting.
"The EU's current approach to biotechnology is inconsistent
with the outcomes obtained from exhaustive scientific risk
assessments of biotech products," Winkles told the members.
"It is imperative that we work together to secure foreign
regulatory acceptance for products enhanced through
biotechnology."
American agriculture continues to be the world leader in the
adoption of agricultural biotechnology, Winkles said. In 2003
biotech crops in the United States accounted for 63 percent of
the world's total plantings.
"If U.S. agriculture is to maintain its place on the
biotechnology frontier, it is imperative that an environment
conducive to innovation and adoption of new technologies is
fostered," concluded Winkles. "Government and private-sector
research and development centers should be reassured that the
United States is working to ensure that there will be a market
both domestically and internationally for approved products
derived from biotechnology."
# # #
AFBF |